D3 pre-mRNA processing in chronic psychosis
慢性精神病中的 D3 mRNA 前体加工
基本信息
- 批准号:6832176
- 负责人:
- 金额:$ 23.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-04-01 至 2006-11-30
- 项目状态:已结题
- 来源:
- 关键词:RNA splicingRNase protection assaybehavioral /social science research tagbrain mappingclinical researchcognitiondopamine receptorfos proteingene expressionhuman tissueimmunocytochemistryimmunoprecipitationintermolecular interactionlaboratory mousemolecular assembly /self assemblyneurogeneticsneuropathologyneurophysiologyneuropsychologynucleic acid structurephospholipase Cpostmortemprecursor mRNAprotein isoformsprotein structure functionschizophrenia
项目摘要
DESCRIPTION (provided by applicant):
In brains of patients with chronic psychosis, an abnormally increased
alternative splicing of dopamine D3 receptor-encoded pre-mRNA leads to a
significant decrease in the expression of D3 receptor mRNA and an increased
accumulation of the alternatively-spliced, truncated D3-like mRNA, named D3nf
D3nf mRNA is translated into a protein that participates in heteroligomeric
assemblies with full-length D3-receptor protein. In contrast to monomeric and
homoligomeric D3 proteins, the D3ID30f heteroligomers do not bind ligands with
high affinity. Thus, both enhanced alternative splicing of D3-pre-mRNA and the
heteroligomeric assembly of D3/D3nf proteins lead to a decreased expression of
functional D3 receptors. This competing renewal seeks to extend our previous
postmortem study on the relative expression of D3 and D3nf mRNAs in cortical
regions of a new population of schizophrenic patients and their matched
controls. Further studies use in vivo RNA splicing assays in conjunction with
substrate D3 pre-mRNA to test the role of phospholipase C activity in the
regulation of D3- and D3nf-specific splice-site selections. Additional studies
use knockout mice to study functional consequences of D3 receptor inactivation.
Our studies have shown that D3 receptor inactivation leads to a decreased
expression of at least two genes that modulate neuronal activity (c-fos,
calbindin) in anatomic structures critically involved in those cognitive
processes that are vulnerable to disruption in schizophrenia. Thus, one series
of anatomic and biochemical studies aims at elucidating mechanisms that lead to
a decreased D1-receptor-mediated neocortical c-fos response in mice deficient
for D3 and D2 receptors. Additional behavioral studies on these mutants further
test whether this decreased D1-receptor activity has consequences for their
performance in cognitive tasks. A final series of immunocytochemical
experiments tests whether the expression of the striatal calcium-binding
protein calbindin is decreased in D3 mutants because D3 receptor expression
promotes calbindin expression in ventral striatal neurons that co-express D3
receptors and calbindin or because D3-receptors play a more general role in the
postnatal development of the striatal calbindin-expressing system.
描述(由申请人提供):
在慢性精神病患者的大脑中,
多巴胺D3受体编码的前体mRNA的选择性剪接导致
D3受体mRNA表达显著降低,
选择性剪接、截短的D3样mRNA(命名为D3 nf)的积累
D3 nf mRNA被翻译成一种蛋白质,
与全长D3受体蛋白组装。与单体和
同源寡聚体D3蛋白,D3 ID 30 f异源寡聚体不结合配体,
高亲和力。因此,两者都增强了D3-前mRNA的选择性剪接,
D3/D3 nf蛋白异源寡聚体组装导致
功能性D3受体这一竞争性的更新旨在扩大我们以前的
大鼠死后脑皮质D3和D3 nf mRNA相对表达的研究
新的精神分裂症患者及其匹配人群的区域
对照进一步的研究使用体内RNA剪接测定结合
底物D3前体mRNA,以测试磷脂酶C活性在细胞凋亡中的作用。
D3和D3 NF特异性剪接位点选择的调节。其他研究
使用基因敲除小鼠研究D3受体失活的功能后果。
我们的研究表明,D3受体失活会导致
至少两种调节神经元活性的基因(c-fos,
钙结合蛋白)在解剖结构中的作用,
精神分裂症中易受破坏的过程。因此,一系列
解剖学和生物化学研究的目的是阐明导致
D1-受体介导的c-fos反应在缺乏
D3和D2受体。对这些突变体的进一步行为研究
测试这种D1受体活性的降低是否会对他们的
在认知任务中的表现最后一系列的免疫细胞化学
实验测试纹状体钙结合蛋白的表达是否
蛋白质钙结合蛋白在D3突变体中减少,因为D3受体表达
促进共表达D3的腹侧纹状体神经元中的钙结合蛋白表达
受体和钙结合蛋白,或者因为D3受体在细胞内发挥更普遍的作用。
纹状体钙结合蛋白表达系统的出生后发育。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CLAUDIA SCHMAUSS其他文献
CLAUDIA SCHMAUSS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CLAUDIA SCHMAUSS', 18)}}的其他基金
Epigenetic modulation of antidepressant efficacy
抗抑郁功效的表观遗传调节
- 批准号:
8706970 - 财政年份:2013
- 资助金额:
$ 23.63万 - 项目类别:
Epigenetic modulation of antidepressant efficacy
抗抑郁功效的表观遗传调节
- 批准号:
8582998 - 财政年份:2013
- 资助金额:
$ 23.63万 - 项目类别:
Genetic and environmental modulation of RNA editing
RNA编辑的遗传和环境调节
- 批准号:
7743836 - 财政年份:2008
- 资助金额:
$ 23.63万 - 项目类别:
Genetic and environmental modulation of RNA editing
RNA编辑的遗传和环境调节
- 批准号:
7991781 - 财政年份:2008
- 资助金额:
$ 23.63万 - 项目类别:
Genetic and environmental modulation of RNA editing
RNA编辑的遗传和环境调节
- 批准号:
7563296 - 财政年份:2008
- 资助金额:
$ 23.63万 - 项目类别:
5-HT2C-receptor expression and function in depression
抑郁症中 5-HT2C 受体的表达和功能
- 批准号:
6325053 - 财政年份:2001
- 资助金额:
$ 23.63万 - 项目类别:
5-HT2C-receptor expression and function in depression
抑郁症中 5-HT2C 受体的表达和功能
- 批准号:
6539139 - 财政年份:2001
- 资助金额:
$ 23.63万 - 项目类别:
5-HT2C-receptor expression and function in depression
抑郁症中 5-HT2C 受体的表达和功能
- 批准号:
6639197 - 财政年份:2001
- 资助金额:
$ 23.63万 - 项目类别:
5-HT2C receptor expression and function in depression
抑郁症中5-HT2C受体的表达和功能
- 批准号:
7120761 - 财政年份:2000
- 资助金额:
$ 23.63万 - 项目类别:
D3 PREMRNA PROCESSING IN CHRONIC PSYCHOSIS
慢性精神病中的 D3 前体 RNA 加工
- 批准号:
2864068 - 财政年份:1997
- 资助金额:
$ 23.63万 - 项目类别:
相似海外基金
NOVEL RNASE PROTECTION ASSAY FOR CYTOKINE MRNAS
细胞因子 MRNAS 的新型 RNA 酶保护测定
- 批准号:
6317727 - 财政年份:2000
- 资助金额:
$ 23.63万 - 项目类别:














{{item.name}}会员




